ReviewRadiologie (Heidelberg, Germany)2026
[Varicocele: comparison of minimally invasive treatment options : Endovascular embolization, microsurgery, and patient-tailored treatment selection].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVaricocele is the most common potentially treatable cause of male subfertility. Endovascular embolization is an established minimally invasive alternative to microsurgical ligation.
objectiveTo place the indications, technique, outcomes, and limitations of varicocele embolization in context and to define its role relative to microsurgery. MATERIALS AND
methodsNarrative, guideline- and evidence-based review of current WHO, EAU, AUA/ASRM, and CIRSE recommendations, systematic reviews, meta-analyses, and relevant cohort studies published through July 2026.
resultsTreatment is primarily indicated in men with a palpable varicocele, abnormal semen parameters, and otherwise unexplained infertility; subclinical varicoceles and normal semen analyses do not justify intervention. Technical success of embolization is usually above 90% in experienced centers. Pregnancy rates are broadly similar to those after surgery, while overall morbidity tends to be lower. Recurrence may, however, be more frequent than after high ligation. No embolic agent has proved consistently superior.
conclusionVaricocele embolization is an evidence-based alternative to surgery, particularly for recurrent disease, bilateral or complex venous anatomy, and when rapid recovery is a priority. Treatment should be selected through multidisciplinary, anatomy-based, and shared decision-making.
Indexed as
Identifiers
42864419What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.